Whitepaper: The Use of Positron Emission Tomography (PET) in Pre-clinical Pharmaceutical Research
Positron emission tomography (PET) is a popular nuclear imaging technique used to gain information about specific metabolic functions.
Used in clinical diagnostic and pre-clinical applications, PET is often combined with other imaging technologies, such as magnetic resonance imaging (MRI) and computed tomography (CT) scanning, to incorporate anatomical information. PET provides functional imaging, which shows the spatial distribution of biomolecular activity in living tissues and is therefore particularly useful for evaluating drug candidates in pre-clinical studies.
Related content from this organisation
- Solid- and Liquid-State NMR for monitoring of polysaccharide antigen in the manufacturing process
- Video: ASMS 2019: timsTOF fleX – MALDI Guided SpatialOMx
- Video: ASMS 2019: diaPASEF
- Application Notes & Whitepapers 2017
- Whitepaper: The ‘workhorse technique’ that is still enabling scientists to break new ground after 70+ years